Medical plastics, including medical blisters and body implants, are widely employed in the healthcare industry. They have been considered suitable materials for medical instruments and devices.
Fremont, CA: Material selection for healthcare applications is of utmost importance due to the significant risks associated with human life. The introduction of new materials in this sector is hindered by extensive research, testing, trials, and stringent regulations.
However, bioplastics represent a dynamic transition in the plastics industry, experiencing significant growth in recent years. This expansion is driven by increased commercial acceptability, investments in production, and research and development (R&D) efforts. Bioplastics offer promising alternatives for healthcare applications, providing materials that meet stringent safety standards while also offering environmental benefits compared to traditional plastics.
Stay ahead of the industry with exclusive feature stories on the top companies, expert insights and the latest news delivered straight to your inbox. Subscribe today.
According to the European Bioplastics Association, bioplastics accounted for approximately 1% of the worldwide polymer market in 2021, with growth expected to reach 25% by 2026.
Although consumer products, flexible packaging, and rigid packaging account for 60% of bioplastics use, the other 40% are spread over various sectors.
In the medical business, bioplastic is only employed in a limited number of surgical and biodegradable materials, including body implants such as bones, scaffolds, and breast implants. Their advantages include less invasiveness, enhanced physiological healing, progressive body breakdown, and biocompatibility.
Bioplastics such as polycaprolactone (PCL), polylactic acid (PLA), and polyglycolide (PGL), as well as related co-polymers, have long been utilized commercially as bioresorbable polymers in tissue engineering. Evonik, Corbion, DSM, and Ashland are some of the prominent businesses that produce these commodities.
As per industry estimates, Bioplastics account for less than 3% of medical polymers used in devices and less than 1% of the overall medical polymer market.
3D printing, predicted to rise by around 24% between 2021-26, is a key contributor to the expansion of bioplastics. It allows for fast, accurate, and high-quality customization, making it perfect for creating personalized implants using bioplastic inks (resins).
Disposable, single-use plastics such as face masks, gloves, hair caps, medical packaging, and similar goods that contribute to growing environmental concerns about healthcare waste and lack of a recycling alternative provide a potential customer base for bioplastics in the medical business. Bioplastics can be useful since medical waste is gathered and disposed of systematically.
More in News